Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
25,223
-121
-0.5% -$1.8K ﹤0.01% 3573
2026
Q1
$390K Buy
25,344
+129
+0.5% +$2.15K ﹤0.01% 3268
2025
Q4
$455K Buy
25,215
+11,242
+80% +$193K ﹤0.01% 2967
2025
Q3
$225K Buy
13,973
+41
+0.3% +$600 ﹤0.01% 3208
2025
Q2
$152K Buy
+13,932
New +$156K ﹤0.01% 3113

Other funds holding MESO

Cliff Asness's MESO Position: Q2 2026 in Review

Cliff Asness reduced its Mesoblast (MESO) stake by 0.48% in Q2 2026, selling an estimated $1.8K and leaving 25,223 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

Cliff Asness first reported a position in MESO in Q2 2025 and has held it in 5 quarters since. The position peaked at $455K in Q4 2025. 71 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Cliff Asness held 25,223 shares of Mesoblast worth $341K as of Q2 2026.
  • Cliff Asness sold 121 Mesoblast shares in Q2 2026, an estimated $1.8K.
  • Mesoblast made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3573 holding.
  • Cliff Asness first reported a position in Mesoblast in Q2 2025 and has held it in 5 quarters since.
  • Cliff Asness's Mesoblast position peaked at $455K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.